BRIGHT MINDS BIOSCIENCES INC. - DRUG
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Feb 17, 2026 | SCHEDULE 13G/A | JANUS HENDERSON GROUP PLC | 14.9% | 1,155,995 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Commodore Capital LP | 0.3% | 18,851 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Commodore Capital Master LP | 0.3% | 18,851 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Advisors LLC | 4.6% | 449,290 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Joseph Edelman | 4.6% | 449,290 | View |
| Feb 17, 2026 | SCHEDULE 13G/A | Perceptive Life Sciences Master Fund, Ltd. | 4.6% | 449,290 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Cormorant Asset Management, LP | 10.88% | 1,059,331 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Bihua Chen | 10.88% | 1,059,331 | View |
| Nov 14, 2025 | SCHEDULE 13G | Vivo Opportunity Fund Holdings, L.P. | 6.4% | 454,184 | View |
| Nov 14, 2025 | SCHEDULE 13G | Vivo Opportunity, LLC | 6.4% | 454,184 | View |
| Nov 14, 2025 | SCHEDULE 13G | Vivo Opportunity Cayman Fund, L.P. | 0.7% | 47,433 | View |
| Nov 14, 2025 | SCHEDULE 13G | Vivo Opportunity Cayman, LLC | 0.7% | 47,433 | View |
| Nov 13, 2025 | SCHEDULE 13G | Adage Capital Management, L.P. | 5.58% | 395,743 | View |
| Nov 13, 2025 | SCHEDULE 13G | Robert Atchinson | 5.58% | 395,743 | View |
| Nov 13, 2025 | SCHEDULE 13G | Phillip Gross | 5.58% | 395,743 | View |
| Nov 12, 2025 | SCHEDULE 13G/A | Sio Capital Management, LLC | 2.69% | 190,764 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.